Article
Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3 analogs.
Journal of molecular endocrinology - 1 Jul 2016
Futawaka Kumi, Tagami Tetsuya, Fukuda Yuki, Koyama Rie, Nushida Ayaka, Nezu Shoko, Yamamoto Hironori, Imamoto Miyuki, Kasahara Masato, Moriyama Kenji
Abstract excerpt
The active form of vitamin D3 (1α,25(OH)2D3, also known as calcitriol) controls the expression of target genes via the vitamin D receptor (VDR). Vitamin D-dependent rickets type II (VDDRII) is a congenital disease caused by inactivating mutations in the VDR The condition is treated with high doses of calcitriol, but the therapeutic effects of other synthetic VD3 analogs have not yet been investigated. In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
